Weihai Baihe Biology Technological Past Earnings Performance
Past criteria checks 4/6
Weihai Baihe Biology Technological has been growing earnings at an average annual rate of 12.3%, while the Personal Products industry saw earnings growing at 9.8% annually. Revenues have been growing at an average rate of 2.1% per year. Weihai Baihe Biology Technological's return on equity is 10.3%, and it has net margins of 19.2%.
Key information
12.3%
Earnings growth rate
4.0%
EPS growth rate
| Personal Products Industry Growth | 7.8% |
| Revenue growth rate | 2.1% |
| Return on equity | 10.3% |
| Net Margin | 19.2% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Weihai Baihe Biology Technological makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 828 | 159 | 118 | 32 |
| 31 Dec 23 | 871 | 169 | 119 | 31 |
| 30 Sep 23 | 839 | 160 | 116 | 29 |
| 30 Jun 23 | 845 | 164 | 110 | 27 |
| 31 Mar 23 | 811 | 152 | 103 | 24 |
| 31 Dec 22 | 725 | 138 | 93 | 23 |
| 30 Sep 22 | 711 | 137 | 85 | 20 |
| 30 Jun 22 | 684 | 151 | 83 | 21 |
| 31 Mar 22 | 663 | 147 | 85 | 23 |
| 31 Dec 21 | 662 | 148 | 88 | 24 |
| 31 Dec 20 | 578 | 127 | 85 | 21 |
| 31 Dec 19 | 500 | 74 | 89 | 18 |
| 31 Dec 18 | 507 | 75 | 90 | 18 |
| 31 Dec 17 | 423 | 64 | 74 | 19 |
| 31 Dec 16 | 365 | 62 | 66 | 20 |
Quality Earnings: 603102 has high quality earnings.
Growing Profit Margin: 603102's current net profit margins (19.2%) are higher than last year (18.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 603102's earnings have grown by 12.3% per year over the past 5 years.
Accelerating Growth: 603102's earnings growth over the past year (5%) is below its 5-year average (12.3% per year).
Earnings vs Industry: 603102 earnings growth over the past year (5%) exceeded the Personal Products industry -0.2%.
Return on Equity
High ROE: 603102's Return on Equity (10.3%) is considered low.